1 of 4
2 of 4
3 of 4
4 of 4
Polyclonal Rabbit anti‑Human VAC14 / TRX Antibody (aa125‑159, IHC, WB) LS‑C392896
Polyclonal Rabbit anti‑Human VAC14 / TRX Antibody (aa125‑159, IHC, WB) LS‑C392896
Antibody:
VAC14 / TRX Rabbit anti-Human Polyclonal (aa125-159) Antibody
Application:
IHC, IHC-P, WB
Format:
Unconjugated, Unmodified
Overview
Antibody:
VAC14 / TRX Rabbit anti-Human Polyclonal (aa125-159) Antibody
Application:
IHC, IHC-P, WB
Format:
Unconjugated, Unmodified
Specifications
Description
TRX antibody LS-C392896 is an unconjugated rabbit polyclonal antibody to human TRX (VAC14) (aa125-159). Validated for IHC and WB.
Target
Human VAC14 / TRX
Synonyms
VAC14 | ArPIKfyve | Protein VAC14 homolog | TAX1BP2 | TRX | Vac14 homolog (S. cerevisiae) | Tax1-binding protein 2
Reactivity
Human
(tested or 100% immunogen sequence identity)
Conjugations
Unconjugated
Purification
Protein A purified
Specificity
This VAC14 antibody is generated from a rabbit immunized with a KLH conjugated synthetic peptide between 125-159 amino acids from human VAC14.
Applications
- IHC
- IHC - Paraffin (1:25 - 1:100)
- Western blot (1:2000)
|
Performing IHC? See our complete line of Immunohistochemistry Reagents including antigen retrieval solutions, blocking agents
ABC Detection Kits and polymers, biotinylated secondary antibodies, substrates and more.
|
Presentation
PBS, 0.09% Sodium Azide
Storage
Maintain refrigerated at 2°C to 8°C for up to 6 months. For long term storage store at -20°C.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
Featured Products
Reactivity:
Mouse
Range:
78-5000 pg/ml
Reactivity:
Human
Range:
3.12-200 ng/ml
Reactivity:
Human
Range:
0.312-20 ng/ml
Reactivity:
Pig
Range:
0.156-10 ng/ml
Reactivity:
Pig
Range:
0.78-50 ng/ml
Reactivity:
Human
Range:
0.41-100 ng/ml
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 4/18/2024